Glaukos Q3 Revenue Jumps 58%
Glaukos reported a 58% increase in Q3 revenue, citing iDose TR, Epioxa launches and Corneal Health growth.
Related stories
Osmond Resources Requests Trading Halt Pending Capital-Raising Announcement
Osmond Resources requested a trading halt pending an announcement on a material capital raising.
M impact | EQUITY | Oct 29, 2026, 10:36 PM UTC
Clever Culture Systems Requests Trading Halt
L impact | EQUITY | Oct 29, 2026, 10:35 PM UTC
Financial Institutions Inc Reports Quarterly Results
Financial Institutions Inc reported results for the quarter ended September 30. The supplied wire does not include financial figures.
M impact | EQUITY | Oct 29, 2026, 10:35 PM UTC
Stagwell Reports Quarterly Results Through September 30
Stagwell reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 10:35 PM UTC
Digital Realty Trust Reports Quarterly Results for Quarter Ended September 30
A machine-generated LSEG summary covers Digital Realty Trust’s quarter ended September 30; the supplied text contains no results figures.
M impact | EQUITY | Oct 29, 2026, 10:35 PM UTC
Neo Battery Reports Fiscal 2027 Second-Quarter Results
M impact | EQUITY | Oct 29, 2026, 10:35 PM UTC